These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial. Greze E, Benard M, Hamon I, Casper C, Haddad FE, Boutroy MJ, Hascoët JM. Paediatr Drugs; 2016 Dec; 18(6):443-449. PubMed ID: 27612991 [Abstract] [Full Text] [Related]
27. Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity. Jamali F, Coutts RT, Malek F, Finer NN, Peliowski A. Dev Pharmacol Ther; 1991 Dec; 16(2):78-82. PubMed ID: 1914782 [Abstract] [Full Text] [Related]
35. [Development of plasma xanthine levels in the treatment of apnea in premature infants]. Brazier JL, Renaud H, Ribon B, Faucon G, Sassard J. Therapie; 1978 Apr 28; 33(3):341-55. PubMed ID: 684686 [No Abstract] [Full Text] [Related]
36. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. Poets CF, Darraj S, Bohnhorst B. Biol Neonate; 1999 Oct 28; 76(4):207-13. PubMed ID: 10473894 [Abstract] [Full Text] [Related]
37. Second-degree atrioventricular heart block after doxapram administration. De Villiers GS, Walele A, Van der Merwe PL, Kalis NN. J Pediatr; 1998 Jul 28; 133(1):149-50. PubMed ID: 9672531 [Abstract] [Full Text] [Related]